Embla Medical hf. (LON:0FIW)

Market Cap	1.58B
Revenue (ttm)	637.58M
Net Income (ttm)	53.38M
Shares Out	n/a
EPS (ttm)	0.13
PE Ratio	29.55
Forward PE	23.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34
Average Volume	12,139
Open	31.80
Previous Close	n/a
Day's Range	31.80 - 31.80
52-Week Range	27.43 - 36.30
Beta	0.58
RSI	49.37
Earnings Date	Oct 21, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1971
• Employees: 4,061
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0FIW

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in USD